No Difference in Reoperation Rates for Adjacent Segment Disease (Operative ASD) in Posterior Cervical Fusions Stopping at C7 versus T1/T2: A cohort of 875 Patients - Part 1.

Study design A retrospective cohort study with chart review. Objective To determine if there is a difference in reoperation rates for adjacent segment disease (operative ASD) in posterior cervical fusions (PCF) that stop at -C7 versus -T1/T2. Summary of background data There are surgical treatment challenges to the anatomical complexities of the cervicothoracic junction (CTJ). Current posterior cervical spine surgery is based on the belief that adjacent segment disease (ASD) occurs if fusions are stopped at C7 although there is varying evidence to support this assumption. Methods Patients were followed until validated reoperations for ASD, membership termination, death, or 03/31/2020. Descriptive statistics and five-year crude incidence rates and 95% confidence intervals (CI) for operative ASD for PCF ending at -C7 or -T1/T2 were reported. Time-dependent crude and adjusted, multivariable Cox-Proportional Hazards models were used to evaluate operative ASD rates with adjustment for covariates or risk change estimates more than 10%. Results We identified 875 patients with PCFs (beginning at C3 or C4 or C5 or C6) stopping at either -C7 (n = 470) or -T1/T2 (n = 405) with average follow-up time of 4.6 (±3.3) years and average time to operative ASD of 2.7 (±2.8) yrs. Crude overall incidence rates for stopping at -C7 (2.12% (1.02%-3.86%)) and -T1/T2 (2.48% (1.25%-4.40%)) were comparable with no statistical difference in risk (adjHR = 1.47, 95% CI = 0.61-3.53, P = 0.39). Additionally, we observed no differences in the probability of operative ASD in competing risk time-dependent models (Grey's Test P = 0.448). Conclusion A large cohort of 875 patients with PCFs stopping at -C7 or -T1/T2 with an average follow-up of > 4 years found no statistical difference in reoperation rates for ASD (operative ASD).Level of Evidence: 3.